Przejdź do zawartości
Merck

Identification of in vivo, conserved, TAF15 RNA binding sites reveals the impact of TAF15 on the neuronal transcriptome.

Cell reports (2013-02-19)
Fadia Ibrahim, Manolis Maragkakis, Panagiotis Alexiou, Margaret A Maronski, Marc A Dichter, Zissimos Mourelatos
ABSTRAKT

RNA binding proteins (RBPs) have emerged as major causative agents of amyotrophic lateral sclerosis (ALS). To investigate the function of TAF15, an RBP recently implicated in ALS, we explored its target RNA repertoire in normal human brain and mouse neurons. Coupling high-throughput sequencing of immunoprecipitated and crosslinked RNA with RNA sequencing and TAF15 knockdowns, we identified conserved TAF15 RNA targets and assessed the impact of TAF15 on the neuronal transcriptome. We describe a role of TAF15 in the regulation of splicing for a set of neuronal RNAs encoding proteins with essential roles in synaptic activities. We find that TAF15 is required for a critical alternative splicing event of the zeta-1 subunit of the glutamate N-methyl-D-aspartate receptor (Grin1) that controls the activity and trafficking of NR1. Our study uncovers neuronal RNA networks impacted by TAF15 and sets the stage for investigating the role of TAF15 in ALS pathogenesis.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Sigma-Aldrich
Anti-GAPDH antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Anti-NR1 Antibody, CT, Upstate®, from mouse
Sigma-Aldrich
Anti-NMDAR1 Splice Variant C1 Antibody, Chemicon®, from rabbit